{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fkey-factors-in-later-line-crc-tx-qP_HkORG","width":444,"version":"1.0","type":"rich","title":"Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/9c3966e2-522b-490c-a7fc-5f1e07814acb/vegf-tki-am-podcasticon-crc-tx.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/ff6f01be-35bb-47ac-acf0-915cd77a0e83\" height=\"200\" width=\"100%\" title=\"Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Chiara Cremolini, MD, PhD, and Teresa Macarulla, MD, as they discuss the clinical data that inform how they select later-line treatment for patients with mCRC."}